SEC Form 4 · accession 0000318306-17-000002
ABEONA THERAPEUTICS INC. · ABEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
B Davis Jeffrey
Officer — COO
Period of report
Dec 14, 2017
Accepted (ET)
Dec 18, 2017 · 4:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000318306
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $16.00 | Dec 14, 2017 | A | 20,000 | A | Dec 14, 2018 | Dec 14, 2027 | Common stock | 20,000 | 20,000 | D |
| Stock option (right to buy)F1,F2 | $16.00 | Dec 14, 2017 | A | 60,000 | A | Jan 14, 2019 | Dec 14, 2027 | Common stock | 60,000 | 60,000 | D |
Explanation of responses
- F1100% accelerated vesting on change of control.
- F2After twelve months from the Grant Date option vest 2.0833% monthly. All options vested 48 months from Grant Date.